SCRIPT Accepted to RCN Education Forum Conference

14th February 2025

SCRIPT is delighted to announce that we will be presenting a poster at the Royal College of Nursing (RCN) Education Forum National Conference and Exhibition 2025. The conference will be held at the Technology and Innovation Centre (TIC) in Glasgow and SCRIPT will be presenting the poster on the 31st March 2025.

The poster will showcase how the new Prescriber Ready portfolio aims to standardise pharmacology education for non-medical healthcare professionals (including nurses) at an undergraduate level, preparing them to achieve ‘prescriber readiness’. The conference aims to celebrate the value of inclusive and innovative educational practice that creates a skilled, professional health and social care workforce.

For more information on the RCN Education Forum, click here: https://www.rcn.org.uk/news-and-events/events/uk-education-conference-310325

Back

More News

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

11th June 2026

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

21st May 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...

New Modules Under Development

13th April 2026

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

25th February 2026

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....